Abattis Announces Successful Completion of Acquisition of Green Tree Therapeutics – GlobeNewswire (press release)

VANCOUVER, British Columbia, Jan. 25, 2018 (GLOBE NEWSWIRE) — Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (CSE: ATT) (OTC: ATTBF) is pleased to announce that, further to its news releases dated December 22, 2017 and January 11, 2018, it has completed its acquisition (the “Acquisition”) of Green Tree Therapeutics (“Green Tree”). As a result of the Acquisition, Green Tree is now a wholly-owned subsidiary of Abattis and Green Tree’s products will become available through Abattis’s wholly-owned subsidiary Vergence Naturals Ltd.
“The closing of our acquisition of Green Tree represents a significant milestone for Abattis,” stated Rob Abenante, President and CEO of Abattis.  “We have now expanded our retail presence and established a solid entry point into the vaporizers market. In connection with the Acquisition, we look to merge our complementary businesses to expand our product lines and customer base.”The Company has recently announced an agreement to partner with ABLE BC and earlier this week announced an agreement with Faculty Brewing Co., an ABLE BC member, to create a hemp-infused, cannabinoid-rich, THC-free craft beer.  The acquisition of Green Tree continues to expand

Read More Here...

This entry was posted in Vaporizer E-Cigarette Stocks News. Bookmark the permalink. Follow any comments here with the RSS feed for this post. Trackbacks are closed, but you can post a comment.